Margaret E Macy

Summary

Affiliation: University of Colorado
Country: USA

Publications

  1. pmc Vandetanib mediates anti-leukemia activity by multiple mechanisms and interacts synergistically with DNA damaging agents
    Margaret E Macy
    Department of Pediatrics, Section of Hematology, Oncology, and Bone Marrow Transplantation, University of Colorado Denver, 13123 East 16th Avenue B 115, Aurora, CO 80045, USA
    Invest New Drugs 30:468-79. 2012

Collaborators

Detail Information

Publications1

  1. pmc Vandetanib mediates anti-leukemia activity by multiple mechanisms and interacts synergistically with DNA damaging agents
    Margaret E Macy
    Department of Pediatrics, Section of Hematology, Oncology, and Bone Marrow Transplantation, University of Colorado Denver, 13123 East 16th Avenue B 115, Aurora, CO 80045, USA
    Invest New Drugs 30:468-79. 2012
    ..Taken together, these preclinical data support clinical evaluation of vandetanib, in combination with cytotoxic chemotherapy, for pediatric leukemia...